Are there any side effects or interactions?
Soy products and cooked soybeans are safe
at a wide range of intakes. However, a small percentage of people have allergies to soybeans and thus should avoid soy
products.
Soy isoflavones have been reported to reduce thyroid function in some people.17
A preliminary trial of soy supplementation among healthy Japanese, found that 30 grams (about
one ounce) per day of soybeans for three months, led to a slight reduction in the hormone that
stimulates the thyroid gland.18 Some participants complained of malaise, constipation, sleepiness, and even goiter. These symptoms resolved within a month of
discontinuing soy supplements. However, a variety of soy products have been shown to either
cause an increase in thyroid function19 or produce no change in thyroid
function.20 The clinical importance of interactions between soy and thyroid
function remains unclear. However, in infants with congenital hypothyroidism, soy formula must not be added, nor
removed from the diet, without consultation with a physician, because ingestion of soy may
interfere with the absorption of thyroid medication.21
Most research, including animal studies, report anticancer effects of soy extracts,22
though occasional animal studies have reported cancer-enhancing effects.23 The
findings of several recent studies suggest that consuming soy might, under some circumstances,
increase the risk of breast cancer.
When ovaries have been removed from animals—a situation related to the condition of
women who have had a total hysterectomy—dietary genistein has been reported to
increase the proliferation of breast cancer cells.24 When pregnant rats were
given genistein injections, their female offspring were reported to be at greater
risk of breast cancer.25 Although
premenopausal women have shown decreases in
estrogen levels in response to soy,26 27 pro-estrogenic effects have
also been reported.28 When pre-menopausal women were given soy isoflavones, an
increase in breast secretions resulted—an effect thought to elevate the risk of
breast cancer.29 In yet another trial, healthy breast cells from women previously
given soy supplements containing isoflavones showed an increase in proliferation
rates—an effect that might also increase the risk of breast cancer.30
Of 154 healthy postmenopausal women who received 150 mg of soy isoflavones per day for five
years, 3.9% developed an abnormal proliferation of the tissue that lines the uterus
(endometrial hyperplasia). In contrast, none of 144 women who received a placebo developed
uterine hyperplasia.31 Although no case of uterine cancer was diagnosed during the
study, endometrial hyperplasia is a potential forerunner of uterine cancer. The amount of
isoflavones used in this study is two to three times as much as that used in many other
studies. Nevertheless, the possibility exists that long-term use of isoflavones could cause
uterine hyperplasia, and women taking isoflavones should be monitored appropriately by their
doctor.
Soy contains a compound called phytic acid,
which can interfere with mineral absorption.
Are there any drug
interactions?
Certain medicines may interact with soy. Refer to
drug interactions for a list of those medicines.
1. Ivy JL, Goforth HW Jr, Damon BM, et al. Early postexercise muscle
glycogen recovery is enhanced with a carbohydrate-protein supplement. J Appl Physiol
2002;93:1337–44.
2. Ivy JL. Glycogen resynthesis after exercise: effect of carbohydrate
intake. Int J Sports Med 1998;19:S142–5 [review].
3. Cade JR, Reese RH, Privette RM, et al. Dietary intervention and
training in swimmers. Eur J Appl Physiol 1991;63:210–5.
4. Jentjens RL, van Loon LJ, Mann CH, et al. Addition of protein and
amino acids to carbohydrates does not enhance postexercise muscle glycogen synthesis. J
Appl Physiol 2001;91:839–46.
5. van Hall G, Shirreffs SM, Calbet JA. Muscle glycogen resynthesis
during recovery from cycle exercise: no effect of additional protein ingestion. J Appl
Physiol 2000;88:1631–6.
6. Carrithers JA, Williamson DL, Gallagher PM, et al. Effects of
postexercise carbohydrate-protein feedings on muscle glycogen restoration. J Appl
Physiol 2000;88:1976–82.
7. van Loon LJ, Saris WH, Kruijshoop M, Wagenmakers AJ. Maximizing
postexercise muscle glycogen synthesis: carbohydrate supplementation and the application of
amino acid or protein hydrolysate mixtures. Am J Clin Nutr 2000;72:106–11.
8. Roy BD, Tarnopolsky MA. Influence of differing macronutrient intakes
on muscle glycogen resynthesis after resistance exercise. J Appl Physiol
1998;84:890–6.
9. Levenhagen DK, Gresham JD, Carlson MG, et al. Postexercise nutrient
intake timing in humans is critical to recovery of leg glucose and protein homeostasis. Am
J Physiol Endocrinol Metab 2001;280:E982–93.
10. Kraemer WJ, Volek JS, Bush JA, Ivy JL. Hormonal responses to
consecutive days of heavy-resistance exercise with or without nutritional supplementation.
J Appl Physiol 1998;85:1544–55.
11. Chandler RM, Byrne HK, Patterson JG, et al. Dietary supplements
affect the anabolic hormones after weight-training exercise. J Appl Physiol
1994;76:839–45.
12. Rozenek R, Ward P, Long S, Garhammer J. Effects of high-calorie
supplements on body composition and muscular strength following resistance training. J
Sports Med Phys Fitness 2002;42:340–7.
13. Williams AG, van den Oord M, Sharma A, Jones DA. Is glucose/amino
acid supplementation after exercise an aid to strength training? Br J Sports Med
2001;35:109–13.
14. Lemon PW, Tarnopolsky MA, MacDougall JD, Atkinson SA. Protein
requirements and muscle mass/strength changes during intensive training in novice
bodybuilders. J Appl Physiol 1992;73:767–75.
15. Esmarck B, Andersen JL, Olsen S, et al. Timing of postexercise
protein intake is important for muscle hypertrophy with resistance training in elderly humans.
J Physiol 2001;535:301–11.
16. Stroescu V, Dragan J, Simionescu L, Stroescu OV. Hormonal and
metabolic response in elite female gymnasts undergoing strenuous training and supplementation
with SUPRO Brand Isolated Soy Protein. J Sports Med Phys Fitness
2001;41:89–94.
17. Divi RL, Chang HC, Doerge DR. Antithyroid isoflavones from soybean.
Biochem Pharmacol 1997;54:1087–96.
18. Ishizuki Y, Hirooka Y, Murata Y, Togashi K. [The effects on the
thyroid gland of soybeans administered experimentally in healthy subjects.] Nippon
Naibunpi Gakkai Zasshi 1991;67:622–9. [in Japanese].
19. Forsythe WA. Soy Protein, thyroid regulation and cholesterol
metabolism. Forsythe WA. Soy protein, thyroid regulation and cholesterol metabolism. J
Nutr 1995;125:619S–23S.
20. Bennink MR, Mayle JE, Bourquin LD, Thiagarajan D. Evaluation of soy
protein in risk reduction for colon cancer and cardiovascular disease: Preliminary results.
Second International Symposium on the Role of Soy in Preventing and Treating Chronic
Disease. September 15–18, 1996. Brussels, Belgium.
21. Jabbar MA, Larrea J, Shaw RA. Abnormal thyroid function tests in
infants with congenital hypothyroidism: the influence of soy-based formula. J Am Coll
Nutr 1997;16:280–2.
22. Messina MJ, Persky V, Setchell KD, Barnes S. Soy intake and cancer
risk: a review of the in vitro and in vivo data. Nutr Cancer
1994;21:113–31.
23. Rao CV, Wang C-X, Simi B, et al. Enhancement of experimental colon
cancer by genistein. Cancer Res 1997;57:3717–22.
24. Barnes S. The chemopreventive properties of soy isoflavonoids in
animal models of breast cancer. Breast Cancer Res Treat 1997;46:169–79
[review].
25. Hilakivi-Clarke L, Cho E, Onojafe I, et al. Maternal exposure to
genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat
offspring. Oncol Rep 1999;6:1089–95.
26. Lu L-JW, Anderson KE, Grady JJ, Nagamani M. Effects of soya
consumption for one month on steroid hormones in premenopausal women: implications for breast
cancer risk reduction. Cancer Epidemiol Biomarkers Prev 1996;5:63–70.
27. Nagata C, Takatsuka N, Inaba S, et al. Effect of soymilk consumption
on serum estrogen concentrations in premenopausal Japanese women. J Natl Cancer Inst
1998;90:1830–5.
28. Hargreaves DNF, Potten CS, Harding C, et al. Two-week dietary soy
supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol
Metab 1999;84:4017–24.
29. Petrakis NL, Barnes S, King EB, et al. Stimulatory influence of soy
protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiol
Biomarkers Prev 1996;5:785–94.
30. McMichael-Phillips DF, Harding C, Morton M, et al. Effects of
soy-protein supplementation on epithelial proliferation in the histologically normal human
breast. Am J Clin Nutr 1998;68(suppl):1431S–6S.
31. Unfer V, Casini ML, Costabile L, et al. Endometrial effects of
long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study.
Fertil Steril 2004;82:145–8.